Patients with ESRD have high levels of proinflammatory cytokines, including interleukin (IL)-6, IL-12, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ, which stimulate cancer antigen presentation [52]. Here, IFNG is linked to cancer.